HAE Haemonetics Corporation
$119.19▲ +0.57%
Healthcare
Other
Volume 464.1K
Avg Volume (10D) 649.9K
Key Metrics & Fundamentals
Market Cap
$5.42B
P/E Ratio
57.6
Div Yield
0.00%
52W Range
48.98 - 123.77
% vs 50 MA
9.70%
% vs 200 MA
53.11%
RSI-14
64.8
MACD Histogram
-0.2300
Beta (1Y vs SPY)
-0.01
Free Cash Flow
$44.42M
Gross Rev
$339.38M
Gross Profit
$202.80M
EBITDA
$84.57M
COGS
$136.58M
Operating Exp
$145.35M
Operating Income
$57.46M
EBIT
$57.46M
Pretax Income
$47.57M
Net Income
$33.01M
EPS (Diluted)
0.72
Price & Volume History
Loading chart…
Recent News
Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · Oct 21, 2026 1:02 PM ET
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
CNW Group · Oct 19, 2026 6:11 PM ET
Haemonetics Gets US FDA Approval for PerQseal Elite Vascular Closure System
MT Newswires · Oct 19, 2026 5:00 PM ET
Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System
PR Newswire · Oct 19, 2026 4:15 PM ET
1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down
StockStory · Oct 16, 2026 10:11 AM ET
Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
Zacks · Oct 16, 2026 7:14 AM ET
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?
Zacks · Oct 15, 2026 8:28 AM ET
Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating
MT Newswires · Oct 9, 2026 7:55 AM ET
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Zacks · Oct 9, 2026 6:43 AM ET
3 Cash-Producing Stocks Walking a Fine Line
StockStory · Oct 9, 2026 5:31 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HAE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.